NCT03502265View on ClinicalTrials.gov

Otteroo Case Series

NACompletedINTERVENTIONAL
Enrollment

4

Participants

Timeline

Start Date

April 3, 2018

Primary Completion Date

September 1, 2019

Study Completion Date

September 1, 2019

Conditions
Infants With or at Risk/Concern for Developmental Delay
Interventions
OTHER

Otteroo

Otteroo will be provided for 4 weeks of use, to supplement any standard care. Standard care is not provided.

Trial Locations (1)

90089

Infant Neuromotor Control Laboratory, Los Angeles

All Listed Sponsors
lead

University of Southern California

OTHER

NCT03502265 - Otteroo Case Series | Biotech Hunter | Biotech Hunter